Milind Suraokar

3.6k total citations
29 papers, 2.0k citations indexed

About

Milind Suraokar is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Milind Suraokar has authored 29 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 13 papers in Pulmonary and Respiratory Medicine and 11 papers in Oncology. Recurrent topics in Milind Suraokar's work include MicroRNA in disease regulation (6 papers), Lung Cancer Treatments and Mutations (6 papers) and RNA modifications and cancer (5 papers). Milind Suraokar is often cited by papers focused on MicroRNA in disease regulation (6 papers), Lung Cancer Treatments and Mutations (6 papers) and RNA modifications and cancer (5 papers). Milind Suraokar collaborates with scholars based in United States, Spain and Taiwan. Milind Suraokar's co-authors include Ignacio I. Wistuba, Carmen Behrens, John D. Minna, Alejandro H. Corvalán, David J. Stewart, Chad J. Creighton, Luisa M. Solis, Young Jin Gi, Elsa R. Flores and Yu-Li Lin and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

In The Last Decade

Milind Suraokar

29 papers receiving 2.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Milind Suraokar United States	19	1.4k	717	524	441	106	29	2.0k
Carolyn Cao United States	18	1.3k 0.9×	402 0.6×	709 1.4×	290 0.7×	114 1.1×	30	1.9k
Sergej Skvortsov Austria	24	1.2k 0.9×	605 0.8×	780 1.5×	332 0.8×	146 1.4×	48	2.1k
Sheng-Chieh Hsu Taiwan	16	1.0k 0.7×	364 0.5×	811 1.5×	286 0.6×	97 0.9×	16	1.7k
Lynn Kirkpatrick United States	15	991 0.7×	679 0.9×	295 0.6×	179 0.4×	88 0.8×	23	1.6k
Megumi Iiizumi United States	17	1.1k 0.7×	674 0.9×	494 0.9×	257 0.6×	101 1.0×	19	1.7k
Chandra Bartholomeusz United States	24	1.2k 0.8×	416 0.6×	867 1.7×	321 0.7×	140 1.3×	44	2.0k
Wendy J. Huss United States	22	981 0.7×	497 0.7×	711 1.4×	664 1.5×	70 0.7×	40	1.8k
Fatih Ceteci Germany	14	923 0.6×	503 0.7×	413 0.8×	224 0.5×	55 0.5×	17	1.4k
Elizabeth S. Henson Canada	18	1.5k 1.1×	798 1.1×	465 0.9×	677 1.5×	101 1.0×	34	2.3k

Countries citing papers authored by Milind Suraokar

Since Specialization

Citations

This map shows the geographic impact of Milind Suraokar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Milind Suraokar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Milind Suraokar more than expected).

Fields of papers citing papers by Milind Suraokar

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Milind Suraokar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Milind Suraokar. The network helps show where Milind Suraokar may publish in the future.

Co-authorship network of co-authors of Milind Suraokar

This figure shows the co-authorship network connecting the top 25 collaborators of Milind Suraokar. A scholar is included among the top collaborators of Milind Suraokar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Milind Suraokar. Milind Suraokar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Tan, Xiaochao, Priyam Banerjee, Xin Liu, et al.. (2018). The epithelial-to-mesenchymal transition activator ZEB1 initiates a prometastatic competing endogenous RNA network. Journal of Clinical Investigation. 128(4). 1267–1282. 58 indexed citations

Du, Liqin, Zhenze Zhao, Milind Suraokar, et al.. (2018). LMO1 functions as an oncogene by regulating TTK expression and correlates with neuroendocrine differentiation of lung cancer. Oncotarget. 9(51). 29601–29618. 12 indexed citations

Zudaire, Isabel, María J. Pajares, Jackeline Agorreta, et al.. (2015). Combined clinical and genomic signatures for the prognosis of early stage non-small cell lung cancer based on gene copy number alterations. BMC Genomics. 16(1). 752–752. 12 indexed citations

Riquelme, Erick, Milind Suraokar, Carmen Behrens, et al.. (2014). VEGF/VEGFR-2 Upregulates EZH2 Expression in Lung Adenocarcinoma Cells and EZH2 Depletion Enhances the Response to Platinum-Based and VEGFR-2–Targeted Therapy. Clinical Cancer Research. 20(14). 3849–3861. 59 indexed citations

Du, Liqin, Zhenze Zhao, Elizabeth A. McMillan, et al.. (2014). Genetic Mutation of p53 and Suppression of the miR-17∼92 Cluster Are Synthetic Lethal in Non–Small Cell Lung Cancer due to Upregulation of Vitamin D Signaling. Cancer Research. 75(4). 666–675. 39 indexed citations

Delgado, Oliver, Kimberly Batten, James A. Richardson, et al.. (2014). Radiation-Enhanced Lung Cancer Progression in a Transgenic Mouse Model of Lung Cancer Is Predictive of Outcomes in Human Lung and Breast Cancer. Clinical Cancer Research. 20(6). 1610–1622. 23 indexed citations

Gibbons, Don L., Limo Chen, Sangeeta Goswami, et al.. (2014). Regulation of tumor cell PD-L1 expression by microRNA-200 and control of lung cancer metastasis.. Journal of Clinical Oncology. 32(15_suppl). 8063–8063. 7 indexed citations

Tsao, Anne S., Nusrat Harun, Junya Fujimoto, et al.. (2014). Elevated PDGFRB gene copy number gain is prognostic for improved survival outcomes in resected malignant pleural mesothelioma. Annals of Diagnostic Pathology. 18(3). 140–145. 8 indexed citations

Riquelme, Erick, Milind Suraokar, Jaime Rodriguez‐Canales, et al.. (2014). Frequent Coamplification and Cooperation between C-MYC and PVT1 Oncogenes Promote Malignant Pleural Mesothelioma. Journal of Thoracic Oncology. 9(7). 998–1007. 79 indexed citations

10.

Suraokar, Milind, Lixia Diao, C.F. Behrens, et al.. (2014). Expression profiling stratifies mesothelioma tumors and signifies deregulation of spindle checkpoint pathway and microtubule network with therapeutic implications. Annals of Oncology. 25(6). 1184–1192. 44 indexed citations

11.

Tang, Hao, Guanghua Xiao, Carmen Behrens, et al.. (2013). A 12-Gene Set Predicts Survival Benefits from Adjuvant Chemotherapy in Non–Small Cell Lung Cancer Patients. Clinical Cancer Research. 19(6). 1577–1586. 213 indexed citations

12.

Du, Liqin, Zengren Zhao, Xiuye Ma, et al.. (2013). miR-93-directed downregulation of DAB2 defines a novel oncogenic pathway in lung cancer. Oncogene. 33(34). 4307–4315. 69 indexed citations

13.

Dalvi, Maithili P., Carmen Behrens, Milind Suraokar, et al.. (2012). Abstract 821: Developing a molecular understanding of non small cell lung cancer (NSCLC) resistance to platin-taxane chemotherapy. Cancer Research. 72(8_Supplement). 821–821. 1 indexed citations

14.

Du, Liqin, M. Cecilia Subauste, Christopher DeSevo, et al.. (2012). miR-337-3p and Its Targets STAT3 and RAP1A Modulate Taxane Sensitivity in Non-Small Cell Lung Cancers. PLoS ONE. 7(6). e39167–e39167. 88 indexed citations

15.

Nuñez, Maria I., Carmen Behrens, Denise M. Woods, et al.. (2012). High Expression of Folate Receptor Alpha in Lung Cancer Correlates with Adenocarcinoma Histology and Mutation. Journal of Thoracic Oncology. 7(5). 833–840. 130 indexed citations

16.

Solis, Luisa M., Carmen Behrens, Wenli Dong, et al.. (2010). Nrf2 and Keap1 Abnormalities in Non–Small Cell Lung Carcinoma and Association with Clinicopathologic Features. Clinical Cancer Research. 16(14). 3743–3753. 357 indexed citations

17.

Su, Xiaohua, Deepavali Chakravarti, Min Soon Cho, et al.. (2010). TAp63 suppresses metastasis through coordinate regulation of Dicer and miRNAs. Nature. 467(7318). 986–990. 351 indexed citations

18.

Yang, Peiying, David G. Menter, Carrie Cartwright, et al.. (2009). Oleandrin-mediated inhibition of human tumor cell proliferation: Importance of Na,K-ATPase α subunits as drug targets. Molecular Cancer Therapeutics. 8(8). 2319–2328. 70 indexed citations

19.

Kim, Jeri, Funda Vakar‐Lopez, Anita L. Sabichi, et al.. (2004). Glycogen Synthase Kinase-3β Is Involved in the Phosphorylation and Suppression of Androgen Receptor Activity. Journal of Biological Chemistry. 279(18). 19191–19200. 73 indexed citations

20.

Sands, Arthur, et al.. (1995). p53 deficiency does not affect the accumulation of point mutations in a transgene target.. Proceedings of the National Academy of Sciences. 92(18). 8517–8521. 71 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact